January 3, 2018 / 10:31 AM / 20 days ago

BRIEF-Trendlines Group Says Portfolio ‍Co Received Regulatory Clearance From US FDA For Composite Sinus Stent​‍​

Jan 3 (Reuters) - Trendlines Group Ltd:

* PORTFOLIO ‍CO RECEIVED REGULATORY CLEARANCE FROM UNITED STATES FOOD AND DRUG ADMINISTRATION (FDA) FOR ITS COMPOSITE SINUS STENT​‍​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below